Arteritis, Temporal

Arteritis, Temporal is a topic covered in the 5-Minute Clinical Consult.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --



  • Technically termed giant cell arteritis (GCA)
  • A chronic, generalized, cellular, and humoral immune-mediated vasculitis of large- and medium-sized vessels, predominantly affecting the cranial arteries originating from the aortic arch, although vascular involvement may be widespread. Inflammation of the aorta is observed in 50% of cases.
  • Frequent features include fatigue, headaches, jaw claudication, loss of vision, scalp tenderness, polymyalgia rheumatica (PMR), and aortic arch syndrome (decreased or absent peripheral pulses, discrepancies of blood pressure, arterial bruits).
  • Considered medical emergency due to risk of permanent vision loss if not treated


  • Most common form of systemic vasculitis affecting persons ≥ 50 years old
  • Typically occurs ages 70 to 80 years (80% of cases)
  • Women are affected about 2 times as often as men.
  • Most common vasculitis in individuals of Northern European descent (Scandinavian countries)
  • Rare in Asians and African Americans

  • Prevalence in individuals >50 years: 1 in 500
  • Cyclic incidence: peaking every 5 to 7 years

Etiology and Pathophysiology

  • The exact etiology of GCA remains unknown, although current theory suggests that advanced age, ethnicity, and specific genetic predisposition lead to a maladaptive response to endothelial injury, intimal hyperplasia, and ultimately vascular stenosis.
  • Temporal arteritis (TA) is a chronic, systemic vasculitis primarily affecting the elastic lamina of medium- and large-sized arteries. Histopathology of affected arteries is marked by transmural inflammation of the intima, media, and adventitia, as well as patchy infiltration by lymphocytes, macrophages, and multinucleated giant cells. Mural hyperplasia can result in arterial luminal narrowing, resulting in subsequent distal ischemia.
  • Current theory regarding the etiology of TA is that a maladaptive response to endothelial injury leads to an inappropriate activation of T-cell–mediated immunity via immature antigen-presenting cells. The subsequent release of cytokines within the arterial vessel wall can attract macrophages and multinucleated giant cells, which form granulomatous infiltrates and give diseased vessels their characteristic histology. This also leads to an oligoclonal expansion of T-cells directed against antigens in or near the elastic lamina. Ultimately, this cascade results in vessel wall damage, intimal hyperplasia, and eventual stenotic occlusion.
  • In recent years, GCA and PMR have increasingly been considered to be closely related conditions.
  • Varicella zoster virus has been proposed as possible immune trigger for GCA; however, this has not been substantiated, and adjunctive treatment with antivirals remains controversial.

The gene for HLA-DRB1–04 has been identified as a risk factor for TA, and polymorphisms of ICAM-1 and PTPN-22 have also been implicated.

Risk Factors

  • Increasing age >70 years is the greatest risk factor.
  • Genetic predisposition
  • Environmental factors influence susceptibility.
  • History of smoking
  • Early menopause (<43 years) and lower BMI at menopause in women 50 to 69 years old

Commonly Associated Conditions

Population studies have shown 40–60% of patients diagnosed with GCA also have PMR symptoms, and 16–21% of patient with PMR have GCA.

-- To view the remaining sections of this topic, please or purchase a subscription --